arrow
R

Rajeshwer S. Sankhala

walter reed army institute of research
H指数:22
被引数:1,638

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection

通过瞬时转染生产临床级SARS-CoV-2 Spike Ferritin Nanoparticle Protein免疫原

2026-03-030
OAAI
Antibody sequence determinants of viral antigen specificity
MBIO
IF4.7
2024-10-161
OAAI
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
2024-01-033
OAAI
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
2023-08-017
OAAI
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
2023-07-2712
OAAI
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
2023-03-1812
OAAI
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
2023-02-0316
OAAI
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants
2022-12-258
OAAI
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
2022-05-0420
OAAI
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates
2022-02-1694
OA
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
2021-12-1356
OAAI
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
2021-12-01114
OAAI
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
2021-10-2942
OAAI
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge
2021-10-2854
OAAI
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
2021-09-0143
OAAI
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
2020-02-0369
OAAI